Cargando…

Pharmacological interactions: Synergism, or not synergism, that is the question

Detalles Bibliográficos
Autores principales:	Calzetta, Luigino, Koziol-White, Cynthia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Pharmacology and Drug Interactions Edited by Dr. Luigino Calzetta and Dr. Cynthia Koziol-White
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8663943/ https://www.ncbi.nlm.nih.gov/pubmed/34909673 http://dx.doi.org/10.1016/j.crphar.2021.100046

Ejemplares similares

Drug interaction and chronic obstructive respiratory disorders
por: Rogliani, Paola, et al.
Publicado: (2020)

Tuberculosis and pharmacological interactions: A narrative review
por: Riccardi, Niccolò, et al.
Publicado: (2020)

Pharmacogenomics and circadian rhythms as mediators of cardiovascular drug-drug interactions
por: Geng, Yong-Jian, et al.
Publicado: (2021)

Drug-drug interactions in polypharmacy patients: The impact of renal impairment
por: Papotti, Bianca, et al.
Publicado: (2021)

Gauging the role and impact of drug interactions and repurposing in neurodegenerative disorders()
por: Khatri, Dharmendra Kumar, et al.
Publicado: (2021)

Drug interactions of direct oral anticoagulants in elderly patients with cardiometabolic diseases
por: Bellia, Alfonso, et al.
Publicado: (2021)

The potential roles of Nrf2/Keap1 signaling in anticancer drug interactions
por: Wang, Jingya, et al.
Publicado: (2021)

From dissection of fibrotic pathways to assessment of drug interactions to reduce cardiac fibrosis and heart failure
por: Garoffolo, Gloria, et al.
Publicado: (2021)

Cataract and diabetic retinopathy
por: Rice, James
Publicado: (2011)

Grading diabetic retinopathy (DR) using the Scottish grading protocol
por: Zachariah, Sonia, et al.
Publicado: (2015)

Talking to patients about diabetes and eye health
Publicado: (2015)

Grading images for diabetic retinopathy: tips and guidelines
por: Jamison, Catherine, et al.
Publicado: (2023)

Grading diabetic retinopathy: an introduction
por: Bascaran, Covadonga
Publicado: (2023)

Understanding and managing sight-threatening diabetic retinopathy
por: Yorston, David
Publicado: (2023)

Excellence paves the way with current research in pharmacology and drug discovery
por: Calzetta, Luigino, et al.
Publicado: (2020)

Evaluation of Potential Drug‐Drug Interaction Risk of Pexidartinib With Substrates of Cytochrome P450 and P‐Glycoprotein
por: Zahir, Hamim, et al.
Publicado: (2020)

Edoxaban drug–drug interactions with ketoconazole, erythromycin, and cyclosporine
por: Parasrampuria, Dolly A., et al.
Publicado: (2016)

Rivaroxaban compared with standard thromboprophylaxis after major orthopaedic surgery: co‐medication interactions
por: Kreutz, Reinhold, et al.
Publicado: (2016)

Evaluation of CYP3A‐mediated drug–drug interactions with romidepsin in patients with advanced cancer
por: Laille, Eric, et al.
Publicado: (2015)

Assessment of Clinical Drug‐Drug Interactions of Elagolix, a Gonadotropin‐Releasing Hormone Receptor Antagonist
por: Polepally, Akshanth R., et al.
Publicado: (2020)

CYP‐mediated drug–drug interactions with evacetrapib, an investigational CETP inhibitor: in vitro prediction and clinical outcome
por: Cannady, Ellen A., et al.
Publicado: (2015)

Clinical impact of pharmacokinetic interactions between the HCV protease inhibitor simeprevir and frequently used concomitant medications
por: Marra, Fiona, et al.
Publicado: (2018)

Evaluation of the Pharmacokinetic Drug Interaction of Capmatinib With Itraconazole and Rifampicin and Potential Impact on Renal Transporters in Healthy Subjects
por: Cui, Xiaoming, et al.
Publicado: (2022)

Assessment of Disease‐Related Therapeutic Protein Drug‐Drug Interaction for Etrolizumab in Patients With Moderately to Severely Active Ulcerative Colitis
por: Wei, Xiaohui, et al.
Publicado: (2016)

Metoprolol‐pridopidine drug–drug interaction and food effect assessments of pridopidine, a new drug for treatment of Huntington's disease
por: Rabinovich‐Guilatt, Laura, et al.
Publicado: (2017)

Absence of Drug‐Drug Interaction of Anastrozole on Levonorgestrel Delivered Simultaneously by an Intravaginal Ring: Results of a Phase 2 Trial
por: Nave, Rüdiger, et al.
Publicado: (2019)

A Drug‐Drug Interaction Study to Evaluate the Effect of TAS‐303 on CYP3A Activity in the Small Intestine and Liver
por: Kumagai, Yuji, et al.
Publicado: (2020)

Use of a cocktail probe to assess potential drug interactions with cytochrome P450 after administration of belatacept, a costimulatory immunomodulator
por: Williams, Daphne, et al.
Publicado: (2016)

Drug‐Drug Interaction Study to Assess the Effect of Cytochrome P450 Inhibition and Induction on the Pharmacokinetics of the Novel Cereblon Modulator Avadomide (CC‐122) in Healthy Adult Subjects
por: Ogasawara, Ken, et al.
Publicado: (2019)

Diabetic care initiatives to prevent blindness from diabetic retinopathy in India
por: Murthy, GVS, et al.
Publicado: (2016)

Genetic components in diabetic retinopathy
por: Mishra, Bibhudatta, et al.
Publicado: (2016)

Does tight control of systemic factors help in the management of diabetic retinopathy?
por: Rajalakshmi, Ramachandran, et al.
Publicado: (2016)

Diabetic retinopathy: An epidemic at home and around the world
por: Raman, Rajiv, et al.
Publicado: (2016)

Advances in retinal imaging for diabetic retinopathy and diabetic macular edema
por: Tan, Colin Siang Hui, et al.
Publicado: (2016)

Telemedicine in diabetic retinopathy: Access to rural India
por: Das, Taraprasad, et al.
Publicado: (2016)

Correlation between retinal sensitivity and cystoid space characteristics in diabetic macular edema
por: Velaga, Swetha B, et al.
Publicado: (2016)

DR MURUGAPPAN AWARDS
Publicado: (2019)

The Death of Dr. Brainard
Publicado: (1866)

Effects of Strong CYP3A Inhibition and Induction on the Pharmacokinetics of Ixazomib, an Oral Proteasome Inhibitor: Results of Drug‐Drug Interaction Studies in Patients With Advanced Solid Tumors or Lymphoma and a Physiologically Based Pharmacokinetic Analysis
por: Gupta, Neeraj, et al.
Publicado: (2017)

Lack of Impact by SCY‐078, a First‐in‐Class Oral Fungicidal Glucan Synthase Inhibitor, on the Pharmacokinetics of Rosiglitazone, a Substrate for CYP450 2C8, Supports the Low Risk for Clinically Relevant Metabolic Drug‐Drug Interactions
por: Wring, Stephen, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_9v5u7d7doampki24ucnv48rtjr